RATIONALE: Nitrogen oxide (NO) species are markers for oxidative stress that may be pathogenic in acute lung injury (ALI). OBJECTIVES: We tested two hypotheses in patients with ALI: (1) higher levels of urine NO would be associated with worse clinical outcomes, and (2) ventilation with lower VT would reduce urine NO as a result of less stretch injury. METHODS: Urine NO levels were measured by chemiluminescence in 566 patients enrolled in the National Heart Lung and Blood Institute Acute Respiratory Distress Syndrome Network trial of 6 ml/kg versus 12 ml/kg VT ventilation. The data were expressed corrected and uncorrected for urine creatinine (Cr). RESULTS: Higher baseline levels of urine NO to Cr were associated with lower mortality (odds ratio, 0.43 per log(10) increase in the ratio), more ventilator-free days (mean increase, 1.9 d), and more organ-failure-free days (mean increase, 2.3 d) on multivariate analysis (p < 0.05 for all analyses). Similar results were obtained using urine NO alone. NO to Cr levels were higher on Day 3 in the 6 ml/kg than in the 12 ml/kg VT group (p = 0.04). CONCLUSIONS: Contrary to our hypothesis, higher urine NO was associated with improved outcomes in ALI at baseline and after treatment with the 6 ml/kg VT strategy. Higher endogenous NO may reflect less severe lung injury and better preservation of the pulmonary and systemic endothelium or may serve a protective function in patients with ALI.
RATIONALE: Nitrogen oxide (NO) species are markers for oxidative stress that may be pathogenic in acute lung injury (ALI). OBJECTIVES: We tested two hypotheses in patients with ALI: (1) higher levels of urine NO would be associated with worse clinical outcomes, and (2) ventilation with lower VT would reduce urine NO as a result of less stretch injury. METHODS: Urine NO levels were measured by chemiluminescence in 566 patients enrolled in the National Heart Lung and Blood Institute Acute Respiratory Distress Syndrome Network trial of 6 ml/kg versus 12 ml/kg VT ventilation. The data were expressed corrected and uncorrected for urine creatinine (Cr). RESULTS: Higher baseline levels of urine NO to Cr were associated with lower mortality (odds ratio, 0.43 per log(10) increase in the ratio), more ventilator-free days (mean increase, 1.9 d), and more organ-failure-free days (mean increase, 2.3 d) on multivariate analysis (p < 0.05 for all analyses). Similar results were obtained using urine NO alone. NO to Cr levels were higher on Day 3 in the 6 ml/kg than in the 12 ml/kg VT group (p = 0.04). CONCLUSIONS: Contrary to our hypothesis, higher urine NO was associated with improved outcomes in ALI at baseline and after treatment with the 6 ml/kg VT strategy. Higher endogenous NO may reflect less severe lung injury and better preservation of the pulmonary and systemic endothelium or may serve a protective function in patients with ALI.
Authors: Louis G Chicoine; Michael L Paffett; Tamara L Young; Leif D Nelin Journal: Am J Physiol Lung Cell Mol Physiol Date: 2004-02-20 Impact factor: 5.464
Authors: Roy G Brower; Paul N Lanken; Neil MacIntyre; Michael A Matthay; Alan Morris; Marek Ancukiewicz; David Schoenfeld; B Taylor Thompson Journal: N Engl J Med Date: 2004-07-22 Impact factor: 91.245
Authors: Adrian T Gonon; Deniz Erbas; Anders Bröijersén; Guro Valen; John Pernow Journal: Am J Physiol Heart Circ Physiol Date: 2003-12-23 Impact factor: 4.733
Authors: Carolyn S Calfee; Lorraine B Ware; David V Glidden; Mark D Eisner; Polly E Parsons; B Taylor Thompson; Michael A Matthay Journal: Crit Care Med Date: 2011-04 Impact factor: 7.598
Authors: Carolyn M Hendrickson; Jason Abbott; Hanjing Zhuo; Kathleen D Liu; Carolyn S Calfee; Michael A Matthay Journal: Am J Physiol Lung Cell Mol Physiol Date: 2017-02-17 Impact factor: 5.464
Authors: Zachary T Kelleher; Erin N Potts; Mulugu V Brahmajothi; Matthew W Foster; Richard L Auten; W Michael Foster; Harvey E Marshall Journal: Am J Physiol Lung Cell Mol Physiol Date: 2011-07-01 Impact factor: 5.464
Authors: Judie A Howrylak; Tamas Dolinay; Lorrie Lucht; Zhaoxi Wang; David C Christiani; Jigme M Sethi; Eric P Xing; Michael P Donahoe; Augustine M K Choi Journal: Physiol Genomics Date: 2009-01-27 Impact factor: 3.107
Authors: Tsin W Yeo; Daniel A Lampah; Emiliana Tjitra; Retno Gitawati; Christabelle J Darcy; Catherine Jones; Enny Kenangalem; Yvette R McNeil; Donald L Granger; Bert K Lopansri; J Brice Weinberg; Ric N Price; Stephen B Duffull; David S Celermajer; Nicholas M Anstey Journal: PLoS Pathog Date: 2010-04-22 Impact factor: 6.823
Authors: Ednan K Bajwa; James L Januzzi; Michelle N Gong; B Taylor Thompson; David C Christiani Journal: Crit Care Med Date: 2008-08 Impact factor: 7.598